Takeda Pharmaceutical Cash Flow Statement (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.22B	2.78B	-3.52B	1.35B	1.33B
Share-based Compensation (Quarter)	0.11B	0.10B	0.10B	0.10B	0.12B	0.12B	0.11B	0.11B	0.13B	0.13B	0.12B	0.10B	0.14B	0.12B	0.12B	0.11B	0.13B	0.12B	0.13B	0.11B
Deferred Taxes (Quarter)	0.14B	0.13B	-0.37B	0.39B	0.02B	-0.08B	0.13B	0.33B				0.27B	0.18B	0.02B	-0.03B	0.18B	0.27B	0.20B	-0.55B	0.31B
Gains from Sales and Divestitures (Quarter)	0.00B			0.00B	0.00B			0.00B	-0.00B	0.01B	0.03B	0.01B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.01B	0.00B
Gains from Investment Securities (Quarter)	0.00B	0.02B	0.01B	0.00B	0.02B	0.01B	0.00B	0.00B		0.00B	0.09B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Asset Writedowns and Impairment (Quarter)	0.01B	0.12B	0.34B	0.11B	0.16B	0.04B	0.17B	0.06B	0.82B	0.05B	0.11B	0.17B	0.07B	0.01B	0.45B	0.02B	0.58B	0.05B	0.32B	0.19B
Non-cash Items (Quarter)	2.46B	3.30B	3.57B	0.81B	2.24B	3.07B	2.38B	1.06B	1.84B	1.31B	2.12B	1.32B	2.21B	2.64B	1.77B	1.72B	2.93B	2.57B	0.88B	0.89B
Change in Working Capital (Quarter)					-1.25B		-1.16B		-1.19B
Change in Receivables (Quarter)	-0.12B	1.21B	0.39B	-0.14B	0.09B	0.09B	0.52B	-0.66B	0.12B	0.10B	0.50B	-0.31B	-0.07B	0.08B	-0.09B	0.33B	-0.07B	-0.07B	-0.62B	-0.45B
Change in Inventory (Quarter)	-0.04B	-0.13B	-0.06B	-0.07B	-0.05B	-0.13B	-0.34B	-0.21B	-0.34B	-0.34B	0.09B	-0.06B	-0.28B	0.14B	-0.03B	-0.09B	-0.20B	-0.25B	0.12B	-0.21B
Change in Account Payables (Quarter)	0.14B	0.06B	1.09B	-0.75B	-0.29B	-0.05B	0.45B	-0.25B	-0.10B	0.48B	-0.21B	-0.24B	0.00B	0.13B	0.07B	-0.19B	0.11B	0.02B	0.03B	-0.14B
Change in Accured Expenses (Quarter)				-0.34B							-0.06B			0.05B	0.04B	-0.12B	0.08B			-0.22B
Change in Taxes (Quarter)	-0.39B	-0.25B	-0.35B	-0.19B	-0.66B	-0.41B	-0.19B	-0.41B	-0.51B	-0.34B	-0.27B	-0.24B	-0.34B	-0.21B	-0.33B	-0.25B	-0.37B	-0.16B	-0.41B	-0.11B
Cash from Operations (Quarter)	2.12B	3.06B	3.23B	0.65B	1.60B	2.68B	2.22B	0.67B	1.38B	0.99B	1.88B	1.09B	1.88B	2.52B	1.46B	1.49B	2.57B	2.43B	1.58B	0.80B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	1.28B	1.30B	1.31B	1.22B	1.22B	1.25B	1.22B	1.25B	1.27B	1.27B	1.26B	1.23B	1.29B	1.23B	1.24B	1.26B	1.26B	1.24B	1.04B	1.02B
Investing Activities
Capital Expenditures (Quarter)	-0.28B	-0.24B	1.81B	-0.33B	-0.21B	-0.24B	1.86B	-0.34B	-0.26B	-0.32B	2.07B	-0.37B	-0.33B	-0.30B	2.31B	-0.33B	-0.27B	-0.27B	1.95B	-0.34B
Sales of Property, Plant and Equipment (Quarter)	0.00B	0.00B	0.01B	0.00B	0.00B	-0.00B	0.01B	0.00B	0.06B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.04B		0.00B	0.00B	0.01B
Change in Intangibles (Quarter)	-0.12B	-0.19B	-0.14B	-0.43B	-0.08B	-0.12B	-3.09B	-1.63B	-0.22B	-0.20B	-0.13B	-0.52B	-0.08B	-0.08B	1.05B	-0.19B	0.19B	0.00B		-0.31B
Acquisitions (Quarter)		-0.19B
Divestments (Quarter)			0.22B					0.00B	-0.00B		0.13B	0.02B	0.04B	0.01B	0.07B	0.20B	0.00B	0.02B	0.00B	0.07B
Change in Acquisitions & Divestments (Quarter)	0.16B	0.12B	-0.02B	-0.32B	0.22B	0.23B	-0.18B	-0.49B	-0.05B	0.18B	0.29B	-0.71B	-0.06B	0.25B	0.53B	-0.73B	0.48B	0.32B	-0.11B	-0.50B
Cash from Investing Activities (Quarter)	-0.30B	-0.61B	-0.22B	-0.73B	-0.20B	-0.33B	-3.31B	-1.94B	-0.42B	-0.51B	-0.41B	-1.01B	-0.50B	-0.76B	-0.13B	-0.23B	-0.33B	-1.49B	-0.37B	-0.55B
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	-2.25B	-1.48B	-2.10B	-1.67B	-0.38B	-3.08B	-0.05B	-0.42B	-0.97B	-0.66B	-0.39B	2.03B	-0.74B	-4.31B	-1.98B	-1.49B	-0.08B	-1.25B	-0.49B	-1.13B
Change in Capital Stock
Net Shares Issued and Repurchased (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)	-0.09B	-1.16B	4.80B	-1.00B	-0.08B	-0.91B	4.14B	-0.95B	-0.06B	-0.94B	3.82B	-0.89B	-0.06B	-0.96B	3.91B	-1.00B	-0.06B	-0.97B	3.92B	-0.94B
Additional items
Exchange Rate Effect (Quarter)	0.00B	0.05B	0.17B	0.17B	0.07B	-0.07B	-0.00B	0.11B	0.03B	-0.02B	0.07B	0.11B	-0.28B	0.15B	-0.06B	-0.02B	0.09B	0.15B	0.01B	0.04B
Change in Cash (Quarter)	-0.43B	0.97B	0.91B	-1.75B	1.03B	-0.73B	-1.14B	-1.69B	-0.02B	-0.18B	1.07B	2.12B	0.64B	-2.55B	-0.65B	-0.23B	2.16B	-0.32B	-0.39B	-0.88B
Beginning Cash Balance (Quarter)				6.57B				3.89B				2.94B				2.66B				3.73B
Free Cash Flow (Quarter)	2.40B	3.30B	1.42B	0.98B	1.81B	2.91B	0.36B	1.01B	1.64B	1.31B	-0.19B	1.46B	2.22B	2.82B	-0.86B	1.82B	2.84B	2.70B	-0.37B	1.14B
Net Cash Flow (Quarter)	-0.43B	0.97B	0.91B	-1.75B	1.03B	-0.73B	-1.14B	-1.69B	-0.02B	-0.18B	1.07B	2.12B	0.64B	-2.55B	-0.65B	-0.23B	2.16B	-0.32B	0.71B	-0.88B

Research Tools

Datasets

Plans

Developers

Takeda Pharmaceutical TAK Cash Flow Statement (2017-2026)

Research Tools

Datasets

Plans

Developers

Takeda Pharmaceutical TAK Cash Flow Statement (2017-2026)

Create an account

Sign In

Reset Password